Icecure Medical (Icecure Medical) Revenue per Share : $0.07 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Revenue per Share?

Icecure Medical's revenue per share for the three months ended in Dec. 2023 was $0.03. Icecure Medical's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.07.

Warning Sign:

Icecure Medical Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue Per Share Growth Rate of Icecure Medical was -14.50% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -32.00% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -7.90% per year. During the past 10 years, the average Revenue Per Share Growth Rate was -16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Icecure Medical's Revenue per Share or its related term are showing as below:

ICCM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -48.5 Med: -19.3 Max: 27.1
Current: -32

During the past 11 years, Icecure Medical's highest 3-Year average Revenue Per Share Growth Rate was 27.10% per year. The lowest was -48.50% per year. And the median was -19.30% per year.

ICCM's 3-Year Revenue Growth Rate is ranked worse than
91.83% of 747 companies
in the Medical Devices & Instruments industry
Industry Median: 7 vs ICCM: -32.00

Icecure Medical Revenue per Share Historical Data

The historical data trend for Icecure Medical's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Revenue per Share Chart

Icecure Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue per Share

Get a 7-Day Free Trial

0.12

0.23

0.15

0.08

0.07

Icecure Medical Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Revenue per Share	Get a 7-Day Free Trial															0.03	0.02	0.02	0.01	0.03

Competitive Comparison of Icecure Medical's Revenue per Share

For the Medical Devices subindustry, Icecure Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icecure Medical's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's PS Ratio distribution charts can be found below:

* The bar in red indicates where Icecure Medical's PS Ratio falls into.

Icecure Medical Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Icecure Medical's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )	=	Revenue (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	3.229	/	45.638
	=	0.07

Icecure Medical's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )	=	Revenue (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	1.255	/	45.673
	=	0.03

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07

Icecure Medical (NAS:ICCM) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Icecure Medical Revenue per Share Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Icecure Medical (Icecure Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Revenue per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504

Website

https://www.icecure-medical.com

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.